The anticoagulation length of therapy and risk of new adverse events in venous thromboembolism (ALTERNATIVE) study: Design and survey results
The Anticoagulation Length of Therapy and Risk of New Adverse Events In Venous Thromboembolism (ALTERNATIVE) study was designed to compare the benefits and harms of different treatment options for extended treatment of venous thromboembolism (VTE). In this paper, we describe the study cohort, survey...
Main Authors: | Cecilia Portugal, Margaret C. Fang, Alan S. Go, Hui Zhou, John Chang, Priya Prasad, Dongjie Fan, Elisha A. Garcia, Sue Hee Sung, Kristi Reynolds |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731472/?tool=EBI |
Similar Items
-
The anticoagulation length of therapy and risk of new adverse events in venous thromboembolism (ALTERNATIVE) study: Design and survey results.
by: Cecilia Portugal, et al.
Published: (2022-01-01) -
Choice and Duration of Anticoagulation for Venous Thromboembolism
by: Aroosa Malik, et al.
Published: (2024-01-01) -
Newer oral anticoagulants in venous thromboembolism
by: Sunil Modi, et al.
Published: (2021-01-01) -
Anticoagulant therapy for acute venous thromboembolism
by: Hilal Ermiş, et al.
Published: (2017-09-01) -
The treatment of venous thromboembolism with new oral anticoagulants
by: Davide Imberti
Published: (2013-12-01)